SignatureFD’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-6,620
| Closed | -$6.29K | – | 3289 |
|
|
2024
Q3 | $6.29K | Buy |
+6,620
| New | +$6.29K | ﹤0.01% | 2495 |
|
|
2024
Q2 | – | Sell |
-2,037
| Closed | -$3.22K | – | 3117 |
|
|
2024
Q1 | $3.22K | Buy |
+2,037
| New | +$3.22K | ﹤0.01% | 2665 |
|
|
2023
Q1 | – | Sell |
-373
| Closed | -$545 | – | 3275 |
|
|
2022
Q4 | $545 | Sell |
373
-2,812
| -88% | -$4.11K | ﹤0.01% | 3088 |
|
|
2022
Q3 | $3K | Buy |
3,185
+2,413
| +313% | +$2.27K | ﹤0.01% | 2590 |
|
|
2022
Q2 | $1K | Sell |
772
-355
| -31% | -$460 | ﹤0.01% | 2857 |
|
|
2022
Q1 | $2K | Sell |
1,127
-3,103
| -73% | -$5.51K | ﹤0.01% | 2750 |
|
|
2021
Q4 | $16K | Buy |
4,230
+23
| +0.5% | +$87 | ﹤0.01% | 1866 |
|
|
2021
Q3 | $22K | Buy |
4,207
+3,983
| +1,778% | +$20.8K | ﹤0.01% | 1707 |
|
|
2021
Q2 | $1K | Sell |
224
-720
| -76% | -$3.21K | ﹤0.01% | 2653 |
|
|
2021
Q1 | $5K | Buy |
944
+720
| +321% | +$3.81K | ﹤0.01% | 2104 |
|
|
2020
Q4 | $1K | Buy |
+224
| New | +$1K | ﹤0.01% | 2361 |
|
|
2020
Q3 | – | Sell |
-373
| Closed | -$4K | – | 2570 |
|
|
2020
Q2 | $4K | Buy |
+373
| New | +$4K | ﹤0.01% | 1850 |
|